Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels <3.0ng/ml? A Comparison of Biopsy Results of PCPT and Outcome-Related Information.

Slides:

Advertisements

Similar presentations

Volume 62, Issue 4, Pages (October 2012)

Advertisements

Early Detection of Prostate Cancer in 2007

Volume 56, Issue 5, Pages (November 2009)

Volume 55, Issue 1, Pages 1-8 (January 2009)

Volume 72, Issue 1, Pages (July 2017)

Prostate cancer mortality in screen and clinically detected prostate cancer: Estimating the screening benefit Pim J. van Leeuwen, David Connolly, Anna.

The PSA Era is not Over for Prostate Cancer

Volume 54, Issue 2, Pages (August 2008)

Volume 68, Issue 2, Pages (August 2015)

Volume 57, Issue 1, Pages (January 2010)

Volume 50, Issue 1, Pages (July 2006)

Volume 52, Issue 1, Pages (July 2007)

Volume 51, Issue 2, Pages (February 2007)

Volume 62, Issue 5, Pages (November 2012)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 59, Issue 1, Pages (January 2011)

Testosterone Therapy in Men With Prostate Cancer

Volume 53, Issue 4, Pages (April 2008)

Prostate Cancer 2008: Challenges in Diagnosis and Management

Volume 62, Issue 5, Pages (November 2012)

Volume 71, Issue 1, Pages (January 2017)

Volume 61, Issue 5, Pages (May 2012)

Volume 68, Issue 5, Pages (November 2015)

Volume 73, Issue 6, Pages (June 2018)

Volume 53, Issue 5, Pages (May 2008)

Volume 61, Issue 2, Pages (February 2012)

Prostate Cancer Epidemic in Sight?

Volume 65, Issue 6, Pages (June 2014)

Volume 61, Issue 3, Pages (March 2012)

Volume 63, Issue 4, Pages (April 2013)

Volume 54, Issue 4, Pages (October 2008)

Elizabeth K. Bancroft, Rosalind A. Eeles

Volume 53, Issue 4, Pages (April 2008)

Prostate Cancer Detection: A View of the Future

Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance Adam B. Weiner, Ruth Etzioni, Scott E. Eggener

Volume 68, Issue 3, Pages (September 2015)

Volume 56, Issue 2, Pages (August 2009)

Volume 66, Issue 3, Pages (September 2014)

Volume 66, Issue 6, Pages (December 2014)

Prostate Cancer Epidemic in Sight?

The PSA Era is not Over for Prostate Cancer

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 53, Issue 4, Pages (April 2008)

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 65, Issue 6, Pages (June 2014)

Volume 68, Issue 4, Pages (October 2015)

Two-years Postradiotherapy Biopsies: Lessons from MRC RT01 Trial

Volume 48, Issue 6, Pages (December 2005)

Volume 64, Issue 4, Pages (October 2013)

Volume 50, Issue 5, Pages (November 2006)

Volume 53, Issue 1, Pages (January 2008)

Volume 59, Issue 4, Pages (April 2011)

Volume 72, Issue 1, Pages (July 2017)

Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg

Thomas Steuber, Matthew Frank O'Brien, Hans Lilja European Urology

Volume 74, Issue 6, Pages (December 2018)

Prostate Cancer 2008: Challenges in Diagnosis and Management

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.

The Comparability of Models for Predicting the Risk of a Positive Prostate Biopsy with Prostate-Specific Antigen Alone: A Systematic Review Fritz Schröder,

Volume 52, Issue 6, Pages (December 2007)

Volume 68, Issue 2, Pages (August 2015)

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Volume 53, Issue 2, Pages (February 2008)

Volume 74, Issue 6, Pages (December 2018)

Volume 51, Issue 2, Pages (February 2007)

Volume 54, Issue 3, Pages (September 2008)

Does PSA Testing Influence the Natural History of Prostate Cancer?

Volume 52, Issue 5, Pages (November 2007)

European Urology Oncology

Volume 76, Issue 1, Pages (July 2019)

Presentation transcript:

Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels <3.0ng/ml? A Comparison of Biopsy Results of PCPT and Outcome-Related Information from ERSPC Fritz H. Schröder, Chris H. Bangma, Monique J. Roobol European Urology Volume 53, Issue 5, Pages 901-908 (May 2008) DOI: 10.1016/j.eururo.2008.01.048 Copyright © 2008 European Association of Urology Terms and Conditions

Fig. 1 Consort diagram. Prostate cancer detection in men initially presenting with serum PSA values <3.0ng/ml during initial and repeat screenings or as interval cancers (ERSPC Rotterdam, screening interval of 4 yr). PSA=prostate-specific antigen; ERSPC=European Randomized Study of Screening for Prostate Cancer; PCa=prostate cancer. European Urology 2008 53, 901-908DOI: (10.1016/j.eururo.2008.01.048) Copyright © 2008 European Association of Urology Terms and Conditions